Showing 641 - 660 results of 162,906 for search '(( 2 a decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 1.32s Refine Results
  1. 641
  2. 642

    Image_5_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  3. 643

    Suppression of APN/CD13 expression by siRNA induced a marked decrease in migratory potential of ES-2 cells by Mikio Terauchi (35139)

    Published 2011
    “…</p><p>Published online 27 Jul 2007</p><p>PMCID:PMC2000898.</p><p></p> A; Western blot analysis showed a decrease in APN/CD13 expression after siRNA transfection. …”
  4. 644

    (R)-albuterol decreases cytokine protein levels in activated T cells by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”
  5. 645

    (R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”
  6. 646
  7. 647
  8. 648
  9. 649
  10. 650
  11. 651

    Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub> by James R. Neilson (1896145)

    Published 2012
    “…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
  12. 652

    Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub> by James R. Neilson (1896145)

    Published 2012
    “…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
  13. 653

    Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub> by James R. Neilson (1896145)

    Published 2012
    “…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
  14. 654

    Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub> by James R. Neilson (1896145)

    Published 2012
    “…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
  15. 655
  16. 656
  17. 657

    Hepatic irradiation decreases the proportion of DX5<sup>–</sup>TRAIL<sup>+</sup> lrNK cells for up to two months. by Ryosuke Nakano (4557097)

    Published 2018
    “…NK cells were divided into DX5<sup>–</sup>TRAIL<sup>+</sup> lrNK cells and DX5<sup>+</sup>TRAIL<sup>−</sup> cNK cells. …”
  18. 658
  19. 659
  20. 660

    DataSheet2_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.pdf by Sunil Veeravalli (5074115)

    Published 2022
    “…Our results indicate a microbial contribution to the phenotypic characteristic of Fmo5<sup>−/−</sup> mice of decreased plasma cholesterol and identify 2,3-butanediol as a potential agent for lowering plasma cholesterol.…”